International Journal of Pediatric Otorhinolaryngology
Volume 74, Issue 4 , Pages 338-342 , April 2010

Propranolol therapy for infantile haemangiomas: Review of the literature

  • A.P. Zimmermann

      Affiliations

    • Corresponding Author InformationCorresponding author at: Department of Otolaryngology, Head and Neck Surgery, University Hospital Giessen & Marburg, Campus Marburg, Deutschhausstr. 3, 35037 Marburg, Germany. Tel.: +49 6421 5866478; fax: +49 6421 5866367.
    • ,
  • S. Wiegand
    • ,
  • J.A. Werner
    • ,
  • B. Eivazi

Received 6 October 2009 ,Revised 30 December 2009 ,Accepted 5 January 2010.

References 

  1. Chang LC, Haggstrom AN, Drolet BA, Baselga E, Chamlin SL, Garzon MC, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics. 2008;122:360–367
  2. Léauté-Labrèze C, Taieb A. Efficacy of beta-blockers in infantile haemangiomas: the physiopathological significance and therapeutic consequences. Ann. Dermatol. Venerol. 2008;135:860–862
  3. Eivazi B, Ardelean M, Bäumler W, Berlien HP, Cremer H, Elluru R, et al. Update on haemangiomas and vascular malformations of the head and neck. Eur. Arch. Otorhinolaryngol. 2009;266:187–197
  4. Werner JA, Dünne AA, Lippert BM, Folz BJ. Optimal treatment of vascular birthmarks. Am. J. Clin. Dermatol. 2003;4:745–756
  5. Buckmiller L, Dyamenahalli U, Richter GT . Propranolol for airway hemangiomas: case report of novel treatment. Laryngoscope. 2009;(Epub ahead of print)
  6. Nguyen J, Fay A. Pharmacological therapy for periocular infantile haemangiomas: a review of the literature. Semin. Othalmol. 2009;24:178–184
  7. Vlahovic A, Simic R, Djokic D, Ceran C. Diffuse neonatal hemangiomatosis treatment with cyclophosphamide: a case report. J. Pediatr. Hematol. Oncol. 2009;31:858–860
  8. Gottschling S, Schneider G, Meyer S, Reinhard H, Dill-Mueller D, Graf N. Two infants with life-threatening diffuse neonatal hemangiomatosis treated with cyclophosphamide. Pediatr. Blood Cancer. 2006;46:239–242
  9. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe haemangiomas of infancy. N. Engl. J. Med. 2008;358:2649–2651
  10. Helfand M, Peterson K, Dana T. Drug Class Review on Beta Adrenergic Blockers. 2007;http://www.ohsu.edu/drugeffectiveness/reports/final.cfm
  11. Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for haemangiomas of infancy. N. Engl. J. Med. 2008;359:2846–2847
  12. Frazer K. In: Proceedings of the 67th Annual Meeting of the American Academy of Dermatology. San Francisco California, USA, 6–10 March. 2009;Frazer K. Am. J. Clin. Dermatol. 2009;10:205–210
  13. Annabi B, Lachambre MP, Plouffe K, Moumdjian R, Béliveau R. Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metallopteinase-9 secretion. Pharmacol. Res. 2009;(Epub ahead of print)
  14. Cremer HJ, Kachel W, Kosel C. Propranolol in der Behandlung problematischer Hämangiome. Kinder- und Jugendarzt 40.Jg; 2009;(Nr. 7)
  15. Theletsane T, Redferjn A, Raynham O, Harris T, Prose NS, Khumalo NP. Life-threatenting infantile haemangioma: a dramatic response to propranolol. J Eur Acad Dermatol Venerol. 2009;(Epub ahead of print)
  16. Itani MH, Fakih H. Response of facial haemangioma to oral propranolol. BMJ Case Rep. 2009;
  17. Bigorre M, Van Kien AK, Valette H. Beta-blocking agent for treatment of infantile hemangioma. Plast. Reconstr. Surg. 2009;123:195e–196e
  18. Denoyelle F, Leboulanger N, Enjolras O, Harris R, Roger G, Garabedian EN. Role of propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma. Int. J. Pediatr. Otorhinolaryngol. 2009;73:1168–1173
  19. Bonifazi E, Colonna V, Mazzotta F, Balducci G, Laforgia N. Propranolol in rapidly growing hemangiomas. Eur. J. Pediatr. Dermatol. 2008;18:185–192
  20. Sánchez Pérez R, Cortes Mora P, González Rodrígues JD, Rodríguez Sánchez F, De la Peña de Torres J. Treatment of infantile hemangioma with propranolol. Ann. Pediatr. (Barc.). 2009;(July):(Epub ahead of print)
  21. Eivazi B, Teymoortash A, Stiller S, Cremer HJ, Werner JA. Betablockers—new perspektives for infantile hemangiomas of the head and neck. Laryngorhinootologie. 2009;(Epub ahead of print)
  22. Lawley LP, Siegfried MD, Todd JL. Propranolol treatment for haemangioma of infancy: risks and recommendations. Pediatr. Dermatol. 2009;26:610–614
  23. Sans V, Dumas de la Roque E, Berge J, Grenier N, Boralevi F, Mazereeuw-Hautier J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics. 2009;124(3):

PII: S0165-5876(10)00004-2

doi: 10.1016/j.ijporl.2010.01.001

International Journal of Pediatric Otorhinolaryngology
Volume 74, Issue 4 , Pages 338-342 , April 2010

Article Tools